Surgery Partners, Inc. (SGRY) Tops Q4 EPS by 6c ; Offers Outlook

Surgery Partners, Inc. (NASDAQ: SGRY) reported Q4 EPS of $0.44, $0.06 better than the analyst estimate of $0.38. Revenue for the quarter came in at $735.4 million versus the consensus estimate of $741.45 million.

2024 Outlook

The Company projects 2024 revenues to be greater than $3.0 billion, projects 2024 Adjusted EBITDA to be greater than $495 million.

For earnings history and earnings-related data on Surgery Partners, Inc. (SGRY) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Sharon AI surges premarket; New Oriental gains, Medline slips
• Schwab's May activity shows margin loans nearly double